{"chebi_id":"3207","chebi_name":"budesonide","chebi_synonyms":["(11\u03b2,16\u03b1)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione","11\u03b2,21-dihydroxy-16\u03b1,17\u03b1-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione"],"diffprof_id_observed":["MTBLS3038_0002_00000001","MTBLS5943_0001_00000001"],"diffprof_id_var_observed":[],"inchikey":"VOVIALXJUBGFJZ-KWVAZRHASA-N","inn_name":"budesonide","iupac_name":"11\u03b2,21-dihydroxy-16\u03b1,17\u03b1-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione","num_study_observed":2,"reactome_ids":["R-HSA-1643685","R-HSA-2262752","R-HSA-3371497","R-HSA-382551","R-HSA-382556","R-HSA-5663205","R-HSA-8953897","R-HSA-9679191","R-HSA-9679506","R-HSA-9748784","R-HSA-9757110","R-HSA-9824446"],"reactome_names":["Disease","Cellular responses to stress","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand","Transport of small molecules","ABC-family proteins mediated transport","Infectious disease","Cellular responses to stimuli","Potential therapeutics for SARS","SARS-CoV Infections","Drug ADME","Prednisone ADME","Viral Infection Pathways"],"study_id_observed":["MTBLS3038","MTBLS5943"],"study_id_var_observed":[],"synonym_name":"(11\u03b2,16\u03b1)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione"}